SCHEDULE: Vanguard Group Amends CME Group Stake to 10.1%

The Vanguard Group filed an amendment to its Schedule 13G, disclosing a 10.1% beneficial ownership in CME Group Inc. common stock.

Summary

• The Vanguard Group reported beneficial ownership of 36,248,559 shares of CME Group Inc. common stock.
• This represents 10.10% of the class of securities.
• The Vanguard Group holds 3,697,661 shares with shared voting power and 36,248,559 shares with shared dispositive power.
• No shares are held with sole voting or sole dispositive power.
• An internal realignment occurred on January 12, 2026, where The Vanguard Group, Inc. ceased performing portfolio management services or administering proxy voting.
• Certain subsidiaries or business divisions of The Vanguard Group, Inc. are expected to report beneficial ownership separately going forward.
• The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of CME Group Inc.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It is a standard regulatory disclosure of beneficial ownership by a large institutional investor and does not contain new information regarding the issuer's operational or financial performance.

Positives

• The Vanguard Group's continued significant stake of 10.1% in CME Group Inc. indicates ongoing institutional confidence in the company.

Negatives

• The filing does not contain information that would typically be categorized as negatives regarding the issuer's performance or outlook.

Risks

• The filing does not detail specific risks related to CME Group Inc.'s operations or financial health, as it is a beneficial ownership disclosure.

Future Outlook

The filing is a disclosure of beneficial ownership and does not contain any forward-looking statements or guidance from CME Group Inc. or The Vanguard Group regarding CME Group Inc.'s future performance.

Industry Context

StockSavvy.ai notes that large institutional filings like this Schedule 13G are routine disclosures for major asset managers. The Vanguard Group's continued significant stake in CME Group Inc. reflects its strategy of passive or index-based investing, where it holds positions in companies that are part of its various funds' benchmarks. This filing primarily updates the public on the size of Vanguard's stake following an internal organizational change.

Corporate Governance

Stakeholder Impact

• Shareholders of CME Group Inc. are informed of The Vanguard Group's continued significant institutional ownership, which can be a factor in market stability and liquidity.
• The internal realignment at The Vanguard Group primarily impacts its internal reporting structure and does not directly affect CME Group Inc.'s operations or its relationship with its shareholders.

Next Steps

• The Vanguard Group anticipates that certain subsidiaries or business divisions will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on SEC Release No. 34-39538.

Key Dates

Recommendation

This Schedule 13G filing is a routine disclosure of beneficial ownership by a large institutional investor and does not contain new information about CME Group Inc.'s financial performance, strategic direction, or operational health that would warrant a change in investment recommendation. The 10.1% stake is a significant, but expected, institutional holding. Therefore, a 'hold' recommendation is appropriate as the filing itself does not present a catalyst for buying or selling.

Keywords

CME Group Inc, The Vanguard Group, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Equity Stake, SEC Filing